Forest Loses Bid To Limit Liability In Citalopram IP Suit

Law360, New York (May 7, 2009, 12:00 AM EDT) -- In a patent infringement suit brought by Infosint SA over the antidepressant citalopram, a federal judge has refused to limit Forest Laboratories Inc.'s liability through a law meant to protect "innocent infringers" before they know about a patent.

Judge Lewis A. Kaplan of the U.S. District Court for the Southern District of New York ruled Tuesday that genuine issues of fact remained on the question of whether Forest — which makes and sells the antidepressant as Celexa and Lexapro in the U.S. through license agreements with...
To view the full article, register now.